3-D Matrix, Ltd. - 3-D Matrix, Inc.
A self-assembled peptide was discovered in 1992 by Dr. Shuguang Zhang of MIT.
Our company is globally developing businesses based on various rights associated with self-assembling peptide technology licensed from MIT.
Research of novel medical technologies using the self-assembling peptide, our core technology, has been progressing in multiple fields. PuraMatrix™, the first-generation self-assembling peptide, has the excellent ability to regenerate tissues with high affinity for cells.
Moreover, PuraMatrix™ has been nanostructured with high biodegradability and biocompatibility; therefore, it has gained a high reputation as a drug delivery system (DDS).